NewsRamp Science, Exploration and Discovery Podcast
Subscribed: 0Played: 1
Subscribe
Description
Explore the wonders of science with the 'NewsRamp Science Podcast.' Each episode offers the latest news and detailed summaries from NewsRamp.com, covering scientific breakthroughs, research advancements, and technological innovations. Stay informed on the discoveries that shape our understanding of the world.
30 Episodes
Reverse
BioRestorative Therapies, Inc. reports positive data for its Phase 2 BRTX-100 Chronic Back Pain Trial, ending Q3 in a strong financial position. 340Bwell presents cutting-edge research at international conferences, focusing on optimizing STD clinic resources. Renowned economist Jim Rickards forecasts 'America's Comeback' under a new Trump administration, emphasizing energy policy and nuclear technology. ESTHELIVE introduces a new standard in skincare, focusing on 'wrinkle rehabilitation' with advanced ingredients for youthful, radiant skin.
In this episode, we explore encounters with extraterrestrial craft and beings in rural Wiltshire, as shared by British cyclist Caron Ara. Join us on a journey through time at the Edelman Fossil Park & Museum, set to open in 2025 with immersive exhibits and real fossil digging experiences. Learn about BioRestorative Therapies, Inc.'s groundbreaking stem cell therapies for chronic pain and metabolic disorders, and delve into the booming biotechnology industry with a focus on Impact BioMedical Inc.'s innovative healthcare solutions.
D-Wave Quantum Inc. and Japan Tobacco Inc. collaborate on 'Quantum AI-driven Drug Discovery' to revolutionize pharmaceutical compound identification. The partnership aims to integrate quantum computing into drug development operations, enhancing the speed and quality of AI drug discovery. Visit D-Wave Quantum Inc. newsroom for more details. The 26th WETEX exhibition in Dubai, organized by DEWA, features 68 sponsors, 37 partners, and 2,800 companies from 65 countries. With a focus on sustainability, the event covers 87,494 square meters and includes principal sponsors like Masdar, RTA, and Siemens. Strategic partners such as Empower and SAP contribute to making WETEX a global platform for environmental technology.
Today's episode explores two groundbreaking scientific advancements. The first discusses a new method to reduce nitrate pollution in water systems by enhancing ammonia production efficiency. The study showcases the use of in-situ evolved electrocatalysts like nickel and copper foam cathodes, offering a cleaner alternative for industries reliant on fertilizers and energy. The second segment highlights the development of a bioinspired yarn that can harvest water from fog, inspired by desert beetles and spider silk. This innovative yarn, with alternating hydrophobic and hydrophilic properties, presents a scalable solution for water scarcity in arid regions.
Join us for a special episode covering Blue Innovation Day 2024, a showcase of ocean sustainability technologies and activities in Santa Cruz. Learn about the latest in clean energy solutions, a new study on predicting cardiovascular disease risk using the body roundness index, and explore the unseen world of electricity with author Gerald E. Ulen.
Today's episode explores the innovative approaches of companies like OS Therapies Inc., Actinium Pharmaceuticals, Corbus Pharmaceuticals, and Puma Biotechnology in reshaping cancer treatment. These companies are developing cutting-edge therapies for various types of cancer, showing promising results and strong financial standings in the biotech sector. Additionally, a new scientific statement from the American Heart Association emphasizes the importance of a coordinated healthcare team for children with Trisomy 21 and congenital heart disease, highlighting the need for improved care coordination and support for these individuals.
Today's episode discusses the importance of maintaining good cardiovascular health during the first trimester of pregnancy to potentially offset the genetic risk of developing preeclampsia and gestational hypertension. Research presented at the American Heart Association’s Hypertension Scientific Sessions 2024 shows that focusing on cardiovascular health improvement, nutrition, weight management, and healthy blood pressure early in pregnancy can lower the risk of adverse outcomes. In other news, the 18th Annual Pain Therapeutics Summit in Boston will feature cutting-edge research, innovative treatment strategies, and discussions on the evolving role of patients in clinical research.
Today's episode covers a range of topics from the American Heart Association's Hypertension Scientific Sessions 2024, including the importance of proper cuff sizes for accurate blood pressure monitoring, the effectiveness of bariatric surgery in managing high blood pressure, a program combining remote monitoring and pharmacist interactions to lower blood pressure, concerning trends in high blood pressure among young adults and children, and the groundbreaking potential of Telomir-1 in longevity science. Additionally, official reports on multiple UFO sightings in Brazilian airspace suggest a new chapter in history.
The PAD Collaborative launches an interactive heat map to highlight the risk of lower limb amputations from PAD, emphasizing the need for improved healthcare services and prevention efforts. Brad Morrison from the Texas Space Commission shares Texas' ambitious plans to become a hub for space innovation, focusing on partnerships and initiatives to drive economic growth in the industry.
Today's episode covers groundbreaking research on improving daily streamflow forecasts in data-scarce transboundary basins like the Dulong-Irrawaddy River Basin. The innovative transfer learning model developed by researchers from Yunnan University and Pennsylvania State University sets a new standard for water resource forecasting, offering transformative solutions for water security in vulnerable areas. This study marks a significant advancement in hydrological science, emphasizing the importance of accurate streamflow predictions in enhancing water resource management.
Join us as we explore the future of autonomous aviation with CEO Brandon Robinson of Horizon Aircraft and their groundbreaking Cavorite X7 eVTOL aircraft. Discover how advanced sensors and fly-by-wire systems are paving the way for a future where autonomous air travel could become the norm, offering benefits like bypassing ground traffic and improving safety and efficiency. With promising technical updates and progress on the horizon, Horizon Aircraft is confident in making its vision a reality.
Rogue Space Systems Corporation has been awarded over 1 million dollars for their groundbreaking satellite-characterization upgrades with the Contactless LAser Satellite Stethoscope (CLASS) project. This technology aims to improve space traffic management by identifying and diagnosing Resident-Space-Objects using a laser vibrometer. The success story highlights the impact of SBIR and STTR initiatives on small businesses, as Rogue's CEO and COO discuss the importance of this technology for their fleet of Orbots™ and in-space logistics services.
Join us in this episode as we discuss Panther Minerals Inc.'s strategic growth plans in the booming uranium market, projected to reach $11.38 billion by 2030. The company is actively expanding in North America, focusing on high-quality uranium projects like the Boulder Creek and Fireweed prospects. Utilizing advanced technology like satellite imagery and hyperspectral analysis, Panther Minerals is pinpointing high-potential areas for exploration and has secured permits for a five-year program.
Join us as we discuss Alzamend Neuro, Inc.'s partnership with Massachusetts General Hospital for a Phase II trial of a next-generation treatment for Major Depressive Disorder (MDD). Learn about the innovative approach of using AL001, a lithium-based therapeutic candidate, to address the symptoms of MDD. CEO Stephan Jackman shares his optimism for the potential of AL001 as a safer and more effective alternative for MDD treatment. Alzamend Neuro is also actively involved in Phase II trials for bipolar disorder and Alzheimer's disease, with Dr. Ovidiu Andronesi leading the way.
Join us as we explore Li-FT Power's focus on lithium exploration in Canada with CEO Francis MacDonald. Learn about the high concentrations of lithium found in the Yellowknife Lithium Project and the potential for discovery in Quebec. Discover how the Cali Project in the Northwest Territories positions Li-FT for growth in the near future.
In this episode, we discuss Alzamend Neuro, Inc.'s partnership with Massachusetts General Hospital for a Phase II clinical trial of AL001, a potential game-changer for bipolar disorder treatment. The study aims to establish AL001's safe, effective, and tolerable dosing requirements, potentially simplifying treatment regimens and improving patient compliance. We also explore the rising impact of mental health issues globally and how Alzamend Neuro is advancing new treatments for various conditions. Additionally, we cover BioLumic's innovative use of light to enhance inbred corn lines, with promising results and plans for commercialization in 2025.
Join us as we explore Theriva Biologics' innovative approach to oncolytic virus therapies, aimed at improving survival rates for difficult-to-treat cancers like brain tumors and pancreatic cancers. Learn about their leading candidate, VCN-01, and the promising results seen in clinical trials for various types of cancer. Discover how Theriva is pushing the boundaries with next-generation viruses like VCN-11 with Albumin Shield technology, paving the way for future advancements in cancer treatment.
In this episode, we discuss the rising prevalence of pancreatic cancer and the promising treatment being developed by Oncolytics Biotech Inc. called pelareorep. The GOBLET study is currently testing pelareorep in combination with mFOLFIRINOX and atezolizumab in newly diagnosed metastatic pancreatic cancer patients, with positive results in previous trials and Fast Track Designation from the FDA. This innovative therapy could offer new hope for pancreatic cancer patients and improve outcomes.
Today's episode covers the latest advancements in mental health treatment by MIRA Pharmaceuticals (NASDAQ: MIRA), with promising preclinical trial results for compounds MIRA-55 and Ketamir-2. MIRA-55 offers therapeutic benefits without side effects like increased appetite or paranoia, while Ketamir-2 targets treatment-resistant depression. With a focus on patient care, MIRA aims to improve access and affordability, potentially changing the standard of care for neurological and neuropsychiatric disorders. In other news, Doubleview Gold Corp has resumed drilling at the Hat Project in Northern British Columbia, utilizing technical and statistical models to improve grade and explore mineralization trends for a future Mineral Resource Estimate.
Golden Shield Resources has acquired Tucano Gold, gaining exposure to exploration opportunities at Marudi and a high-grade gold asset in Brazil. The acquisition includes Mina Tucano, an open-pit operation with underground potential, set to restart production in Q4 2024. Classiq has launched Qmod, a high-level language for quantum coding, making quantum computing more accessible. CEO Nir Minerbi believes Qmod will simplify complex problems with its declarative nature and industry readiness.
Comments
Top Podcasts
The Best New Comedy Podcast Right Now – June 2024The Best News Podcast Right Now – June 2024The Best New Business Podcast Right Now – June 2024The Best New Sports Podcast Right Now – June 2024The Best New True Crime Podcast Right Now – June 2024The Best New Joe Rogan Experience Podcast Right Now – June 20The Best New Dan Bongino Show Podcast Right Now – June 20The Best New Mark Levin Podcast – June 2024
Download from Google Play
Download from App Store
United States